Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen

BACKGROUND: Neoadjuvant cisplatin-based chemotherapy is standard care prior to radical cystectomy in patients with muscle-invasive bladder cancer (MIBC). OBJECTIVE: To assess efficacy and safety of two commonly used neoadjuvant schedules with different total doses and dose-intensities of gemcitabine...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Karin Holmsten, Lise Høj Omland, Anne Birgitte Als, Mads Agerbæk, Line Hammer Dohn, Henriette Lindberg, Niels Viggo Jensen, Andreas Carus, Mette Moe, Abolfazl Hosseini, Cecilia Radkiewicz, Helle Pappot, Anders Ullén
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2022-03-01
coleção:	Bladder Cancer
Acesso em linha:	https://doi.org/10.3233/BLC-211556
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!